End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.01 USD | -1.23% | -0.50% | +6.95% |
05-08 | Oculis Holding AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | H.C. Wainwright Adjusts Price Target on Oculis Holding to $28 From $29, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.95% | 499M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- OCS Stock
- News Oculis Holding AG
- Oculis Says Phase 3 Stage 1 Trial of Diabetic Macular Edema Drug Candidate Met Primary, Secondary Endpoints